197 related articles for article (PubMed ID: 22517310)
1. Primary care providers' perspectives on discontinuing prostate cancer screening.
Pollack CE; Platz EA; Bhavsar NA; Noronha G; Green GE; Chen S; Carter HB
Cancer; 2012 Nov; 118(22):5518-24. PubMed ID: 22517310
[TBL] [Abstract][Full Text] [Related]
2. Medical center characteristics associated with PSA screening in elderly veterans with limited life expectancy.
So C; Kirby KA; Mehta K; Hoffman RM; Powell AA; Freedland SJ; Sirovich B; Yano EM; Walter LC
J Gen Intern Med; 2012 Jun; 27(6):653-60. PubMed ID: 22180196
[TBL] [Abstract][Full Text] [Related]
3. Primary Care Physicians Beliefs about Prostate-Specific Antigen Evidence Uncertainty, Screening Efficacy, and Test Use.
Ross LE; Hall IJ; Howard DL; Rim SH; Richardson LC
J Natl Med Assoc; 2018 Oct; 110(5):491-500. PubMed ID: 30129508
[TBL] [Abstract][Full Text] [Related]
4. [Prostate cancer screening using prostate-specific antigen: The views of general and laboratory physicians].
Giménez N; Filella X; Gavagnach M; Allué JA; Pedrazas D; Ferrer F;
Semergen; 2018 Sep; 44(6):409-419. PubMed ID: 29574008
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Clinician Decision-making on Cancer Screening Cessation in Older Adults With Limited Life Expectancy.
Schoenborn NL; Massare J; Park R; Boyd CM; Choi Y; Pollack CE
JAMA Netw Open; 2020 Jun; 3(6):e206772. PubMed ID: 32511720
[TBL] [Abstract][Full Text] [Related]
7. Primary Care Providers' Intended Use of Decision Aids for Prostate-Specific Antigen Testing for Prostate Cancer Screening.
Rim SH; Hall IJ; Massetti GM; Thomas CC; Li J; Richardson LC
J Cancer Educ; 2019 Aug; 34(4):666-670. PubMed ID: 29582364
[TBL] [Abstract][Full Text] [Related]
8. Clinician Factors Associated With Prostate-Specific Antigen Screening in Older Veterans With Limited Life Expectancy.
Tang VL; Shi Y; Fung K; Tan J; Espaldon R; Sudore R; Wong ML; Walter LC
JAMA Intern Med; 2016 May; 176(5):654-61. PubMed ID: 27042937
[TBL] [Abstract][Full Text] [Related]
9. Primary care physicians' reported use of pre-screening discussions for prostate cancer screening: a cross-sectional survey.
Linder SK; Hawley ST; Cooper CP; Scholl LE; Jibaja-Weiss M; Volk RJ
BMC Fam Pract; 2009 Mar; 10():19. PubMed ID: 19296843
[TBL] [Abstract][Full Text] [Related]
10. Variation in prostate-specific antigen screening in men aged 80 and older in fee-for-service Medicare.
Bynum J; Song Y; Fisher E
J Am Geriatr Soc; 2010 Apr; 58(4):674-80. PubMed ID: 20345867
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen testing among the elderly in community-based family medicine practices.
Hudson SV; Ohman-Strickland P; Ferrante JM; Lu-Yao G; Orzano AJ; Crabtree BF
J Am Board Fam Med; 2009; 22(3):257-65. PubMed ID: 19429731
[TBL] [Abstract][Full Text] [Related]
12. National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making.
Drazer MW; Prasad SM; Huo D; Schonberg MA; Dale W; Szmulewitz RZ; Eggener SE
Cancer; 2014 May; 120(10):1491-8. PubMed ID: 24523016
[TBL] [Abstract][Full Text] [Related]
13. Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey.
Leyva B; Persoskie A; Ottenbacher A; Hamilton JG; Allen JD; Kobrin SC; Taplin SH
J Cancer Educ; 2016 Dec; 31(4):693-701. PubMed ID: 26498649
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer.
Hayat Roshanai A; Nordin K; Berglund G
Acta Oncol; 2013 Nov; 52(8):1602-8. PubMed ID: 23421929
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen screening: An update of physician beliefs and practices.
Hall IJ; Rim SH; Massetti GM; Thomas CC; Li J; Richardson LC
Prev Med; 2017 Oct; 103():66-69. PubMed ID: 28793236
[TBL] [Abstract][Full Text] [Related]
16. What Have Patients Been Hearing From Providers Since the 2012 USPSTF Recommendation Against Routine Prostate Cancer Screening?
Haider MR; Qureshi ZP; Horner R; Friedman DB; Bennett C
Clin Genitourin Cancer; 2017 Dec; 15(6):e977-e985. PubMed ID: 28625690
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists.
Fowler FJ; Bin L; Collins MM; Roberts RG; Oesterling JE; Wasson JH; Barry MJ
Am J Med; 1998 Jun; 104(6):526-32. PubMed ID: 9674714
[TBL] [Abstract][Full Text] [Related]
18. Population-based patterns and predictors of prostate-specific antigen screening among older men in the United States.
Drazer MW; Huo D; Schonberg MA; Razmaria A; Eggener SE
J Clin Oncol; 2011 May; 29(13):1736-43. PubMed ID: 21444863
[TBL] [Abstract][Full Text] [Related]
19. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
Qaseem A; Barry MJ; Denberg TD; Owens DK; Shekelle P;
Ann Intern Med; 2013 May; 158(10):761-769. PubMed ID: 23567643
[TBL] [Abstract][Full Text] [Related]
20. PSA testing for men at average risk of prostate cancer.
Armstrong BK; Barry MJ; Frydenberg M; Gardiner RA; Haines I; Carter SM
Public Health Res Pract; 2017 Jul; 27(3):. PubMed ID: 28765854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
